Literature DB >> 6183068

Biosynthesis, axonal transport and turnover of neuronal substance P.

P Keen, A J Harmar, F Spears, E Winter.   

Abstract

In dorsal root ganglia substance P is synthesized ribosomally, probably via a precursor. A second peptide, apparently a modified form of substance P (8-11), is cosynthesized with substance P and transported with it down both dorsal roots and peripheral branches. Four times as much substance P-like immunoreactivity is transported peripherally as centrally. Only 30% of axonal substance P-like immunoreactivity is available for rapid axonal transport and this is transported at a rate of 4.9 mm h-1. Axonal transport is not necessary for substance P synthesis. Doses of anisomycin which inhibit CNS protein synthesis by more than 95% do not cause any fall in substance P levels over an eight-hour period in ganglia, spinal cord or brain, suggesting that turnover is slower than that of conventional transmitters. However, stimulation of the hindlimbs of these animals reduces substance P levels in the dorsal horn. The turnover rate of spinal cord substance P, estimated either by relating the amount transported down dorsal roots to that in terminals or by measuring the decline of substance P levels after intrathecal colchicine, is four to five days. The functional organization of the substance P neuron is discussed with particular reference to the maintenance of peptide levels in terminals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183068     DOI: 10.1002/9780470720738.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

Review 1.  Role of substance P in inflammatory arthritis.

Authors:  N E Garrett; P I Mapp; S C Cruwys; B L Kidd; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  [Molecular basis for pain mediating properties of extracorporeal shock waves].

Authors:  J Hausdorf; C Schmitz; B Averbeck; M Maier
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

Review 3.  Mast cells, neuropeptides and inflammation.

Authors:  M K Church; M A Lowman; P H Rees; R C Benyon
Journal:  Agents Actions       Date:  1989-04

4.  Precursor forms of substance P (SP) in nervous tissue: detection with antisera to SP, SP-Gly, and SP-Gly-Lys.

Authors:  R M Kream; T A Schoenfeld; R Mancuso; A N Clancy; W el-Bermani; F Macrides
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.

Authors:  Hiromi Hiruma; Ayako Saito; Tatsumi Kusakabe; Toshifumi Takenaka; Tadashi Kawakami
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

6.  Pain relief by extracorporeal shockwave therapy: an update on the current understanding.

Authors:  Christoph Schmitz; Rocco DePace
Journal:  Urol Res       Date:  2009-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.